{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:57:15Z","timestamp":1790873835549,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016982","name":"Rising Tide Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012023","name":"National Cancer Centre Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007419","name":"Lee Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019579","name":"SingHealth Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025236","name":"Australasian Gastro-Intestinal Trials Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ebiom.2026.106389","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:50:41Z","timestamp":1784573441000},"page":"106389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-6144","authenticated-orcid":false,"given":"Eva","family":"Segelov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0039-7274","authenticated-orcid":false,"given":"Isabel","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Mouradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2574-487X","authenticated-orcid":false,"given":"Sonia","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-5666","authenticated-orcid":false,"given":"Mark","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-1585","authenticated-orcid":false,"given":"Louise","family":"Nott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo Fuang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabilah","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-3825","authenticated-orcid":false,"given":"Estelle","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Chong","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver M.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-7563","authenticated-orcid":false,"given":"John","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2026.106389_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ebiom.2026.106389_bib2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/ijms27031288","article-title":"The anti-metastatic role of aspirin in cancer: a systematic review","volume":"27","author":"Kanwal","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106389_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2026.106389_bib4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2024.05.084","article-title":"Aspirin hypersensitivity in patients with atherosclerotic cardiovascular disease","volume":"84","author":"Galli","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2026.106389_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","article-title":"Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies","volume":"18","author":"Qiao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2026.106389_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","article-title":"Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019","volume":"31","author":"Bosetti","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2468-1253(24)00387-X","article-title":"Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"Chia","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2026.106389_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106389_bib9","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","article-title":"Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer","volume":"31","author":"Domingo","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/0284186X.2014.990158","article-title":"Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib11","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1038\/ctg.2017.18","article-title":"Aspirin use and colon cancer survival in a population-based cohort study","volume":"8","author":"Gray","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106389_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-022-04430-y","article-title":"Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited","volume":"79","author":"Hall","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2026.106389_bib13","article-title":"Adjuvant aspirin treatment in PIK3CA mutated Colon cancer patients: the SAKK 41\/13 - prospective randomized placebo-controlled double-blind trial","volume":"11","author":"G\u00fcller","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106389_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"Low-Dose aspirin for PI3K-Altered localized colorectal cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106389_bib15","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106389_bib16","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1158\/1078-0432.CCR-08-1841","article-title":"Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer","volume":"14","author":"Ogino","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106389_bib17","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.2147\/OTT.S263977","article-title":"Inhibition of PI3K-AKT signaling blocks PGE2-Induced COX-2 expression in lung adenocarcinoma","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ebiom.2026.106389_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The role of Cyclooxygenase-2 in colorectal cancer","volume":"17","author":"Sheng","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ebiom.2026.106389_bib19","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1158\/1078-0432.CCR-12-3614","article-title":"PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer","volume":"19","author":"Day","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106389_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41698-018-0073-y","article-title":"Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer data","volume":"3","author":"Patterson","year":"2019","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib21","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1200\/JCO.23.01680","article-title":"Improved Survival with Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB\/SWOG 80702 (Alliance)","volume":"42","author":"Nowak","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib22","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106389_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMe2508634","article-title":"An aspirin a day for improved colorectal cancer outcomes","volume":"393","author":"Goldberg","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106389_bib24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and Cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2026.106389_bib25","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.3390\/ijms21239018","article-title":"Mechanisms of colorectal cancer prevention by Aspirin-A literature review and perspective on the role of COX-Dependent and -Independent pathways","volume":"21","author":"Sankaranarayanan","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106389_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100109","article-title":"Platelet activation, aspirin, and cancer: from basic science to clinical trials","volume":"78","author":"Patrono","year":"2026","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2026.106389_bib27","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","article-title":"Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer","volume":"31","author":"Yanagisawa","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106389_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4292\/wjgpt.v5.i1.40","article-title":"Aspirin, cyclooxygenase inhibition and colorectal cancer","volume":"5","author":"Sostres","year":"2014","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2026.106389_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41523-020-00204-6","article-title":"S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue","volume":"6","author":"Jindal","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ebiom.2026.106389_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-022-01575-3","article-title":"Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression","volume":"24","author":"Yaghjyan","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106389_bib31","article-title":"Role of aspirin in cancer prevention","volume":"43","author":"Sun","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ebiom.2026.106389_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bmb\/ldw028","article-title":"The role of aspirin in preventing colorectal cancer","volume":"119","author":"Burn","year":"2016","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ebiom.2026.106389_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106389_bib34","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106389_bib35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106389_bib36","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMcibr2502386","article-title":"Understanding how aspirin prevents metastasis","volume":"393","author":"Langley","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106389_bib37","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1158\/1078-0432.CCR-25-0953","article-title":"\u201cPIK\u201ding the right patients for adjuvant aspirin therapy for colorectal cancer","volume":"31","author":"Drew","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106389_bib38","series-title":"Aspirin After Radical Therapy for Colorectal Cancer: A Prospective Meta-Analysis","author":"Burdett","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106389_bib39","series-title":"NCCN Clinical Practice Guidelines in Oncology: Colon CANCER (Version 4)","year":"2025"},{"key":"10.1016\/j.ebiom.2026.106389_bib40","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S2468-1253(19)30289-4","article-title":"Aspirin as adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial","volume":"4","author":"Langley","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2026.106389_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.dld.2017.12.023","article-title":"Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)","volume":"50","author":"Michel","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ebiom.2026.106389_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/jjco\/hyz106","article-title":"Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)","volume":"49","author":"Miyamoto","year":"2019","journal-title":"Jpn J Clin Oncol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:19:27Z","timestamp":1786522767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S2352396426002732"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106389","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106388","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106389"}}